Search Results - "Egger, J L"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    438OMETEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

    438OMETEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours by Siu, L L, Rasco, D W, Vinay, S Postel, Romano, P Martin, Menis, J, Opdam, F L, Heinhuis, K M, Egger, J L, Gorman, S A, Parasrampuria, R, Wang, K, Kremer, B E, Gounder, M M

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background PRMT5 is an enzyme that methylates arginines in proteins important for tumor growth and development. GSK3326595 is a potent and selective…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Mechanical properties of 18 different AO bone plates and the clamp-rod internal fixation system tested on a gap model construct

    Mechanical properties of 18 different AO bone plates and the clamp-rod internal fixation system tested on a gap model construct by Zahn, K, Frei, R, Wunderle, D, Linke, B, Schwieger, K, Guerguiev, B, Pohler, O, Matis, U

    “…To compare the stiffness and strength of AO bone plates (DCP, LC-DCP, VCP, RCP, and LP) and the Clamp-Rod Internal Fixation System (CRIF). In vitro. 12…”
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: